Ning Li

Neoadjuvant PD-1 inhibitor (Sintilimab) in NSCLC

Shugeng Gao, Ning Li, Shun‐Yu Gao et al. · Journal of Thoracic Oncology · 2020 · 415 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Hypofractionated versus conventional fractionated postmastectomy radiotherapy for patients with high-risk breast cancer: a randomised, non-inferiority, open-label, phase 3 trial

Shu-Lian Wang, Hui Fang, Yong-Wen Song et al. · The Lancet Oncology · 2019 · 404 citations

Medicine, Oncology, Radiation Oncology +14

Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study

Yuankai Shi, Junling Li, Shucai Zhang et al. · PLoS ONE · 2015 · 205 citations · Full text

Medicine, Molecular Medicine, Oncology +14

Nanoparticle-based medicines in clinical cancer therapy

Shuhang Wang, Keman Cheng, Kun Chen et al. · Nano Today · 2022 · 167 citations

Pharmacy, Oncology, Pharmacology +14

CAR-macrophage: An extensive immune enhancer to fight cancer

Shuhang Wang, Yuqi Yang, Peiwen Ma et al. · EBioMedicine · 2022 · 122 citations · Full text

Medicine, Immunology, Oncology +17